Skip to main content
Clinical Trials/ISRCTN10416636
ISRCTN10416636
Active, not recruiting
Phase 2

Closed-Loop Electronic stimulation - Mechanomyogram sensor system for Passive tremor Suppression treatment (CLEMPTS)

St George’s University Hospitals NHS Foundation Trust0 sites20 target enrollmentApril 14, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Parkinson's disease-related tremor and essential tremor
Sponsor
St George’s University Hospitals NHS Foundation Trust
Enrollment
20
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 14, 2023
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
St George’s University Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults aged over 18 years
  • 2\. Diagnosed with essential tremor or Parkinson's related tremor by a neurologist with expertise in movement disorders
  • 3\. Functional disability due to tremor reported by patient or clinician
  • 4\. Willing and able to give informed consent

Exclusion Criteria

  • 1\. Cognitive impairment (judged by the clinician on the care team or in the research team as a participant not having sufficient mental capacity to understand the study and its requirements). This includes anyone who, in the opinion of clinicians on the care team or clinicians in the research team, is unlikely to retain sufficient mental capacity for the duration of their involvement in the study.
  • 2\. Subject has a severe medical or psychiatric illness that would interfere with completing initial and follow\-up assessments
  • 3\. Participation in concurrent research which involves a novel therapeutic IMP or device
  • 4\. Although the device is not expected to interfere with pregnancy, women who are pregnant would not be eligible to take part
  • 5\. Active treatment with an implantable stimulation device (such as a cardiac pacemaker or deep brain stimulation implantable programmable generator)
  • 6\. Allergies to neoprene, mylar, electrode hydrogel or medical tape

Outcomes

Primary Outcomes

Not specified

Similar Trials